Open Access System for Information Sharing

Login Library

 

Article
Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Tetrahydrobiopterin enhances mitochondrial biogenesis and cardiac contractility via stimulation of PGC1 alpha signaling

Title
Tetrahydrobiopterin enhances mitochondrial biogenesis and cardiac contractility via stimulation of PGC1 alpha signaling
Authors
Kim, H.K.Jeon, J.Song, I.-S.Heo, H.J.Jeong, S.H.Long, L.T.Thu, V.T.Ko, T.H.Kim, M.Kim, N.Lee, S.R.Yang, J.-S.Kang, M.S.Ahn, J.-M.Cho, J.-Y.Ko, K.S.Rhee, B.D.Nilius, B.Ha, N.-C.Shimizu, I.Minamino, T.Cho, K.I.Park, Y.S.Kim, S.Han, J.
Date Issued
Nov-2019
Publisher
ELSEVIER
Abstract
Tetrahydrobiopterin (BH4) shows therapeutic potential as an endogenous target in cardiovascular diseases. Although it is involved in cardiovascular metabolism and mitochondrial biology, its mechanisms of action are unclear. We investigated how BH4 regulates cardiovascular metabolism using an unbiased multiple proteomics approach with a sepiapterin reductase knock-out (Spr(-/-)) mouse as a model of BH4 deficiency. Spr(-/-) mice exhibited a shortened life span, cardiac contractile dysfunction, and morphological changes. Multiple proteomics and systems-based data-integrative analyses showed that BH4 deficiency altered cardiac mitochondrial oxidative phosphorylation. Along with decreased transcription of major mitochondrial biogenesis regulatory genes, including Ppargc1a, Ppara, Esrra, and Tfam, Spr(-/-) mice exhibited lower mitochondrial mass and severe oxidative phosphorylation defects. Exogenous BH4 supplementation, but not nitric oxide supplementation or inhibition, rescued these cardiac and mitochondrial defects. BH4 supplementation also recovered mRNA and protein levels of PGC1 alpha and its target proteins involved in mitochondrial biogenesis (mtTFA and ERR alpha), antioxidation (Prx3 and SOD2), and fatty acid utilization (CD36 and CPTI-M) in Spr(-/-) hearts. These results indicate that BH4-activated transcription of PGC1 alpha regulates cardiac energy metabolism independently of nitric oxide and suggests that BH4 has therapeutic potential for cardiovascular diseases involving mitochondrial dysfunction.
URI
http://oasis.postech.ac.kr/handle/2014.oak/100214
ISSN
0925-4439
Article Type
Article
Citation
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, vol. 1865, no. 11, 2019-11
Files in This Item:
There are no files associated with this item.

qr_code

  • mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher

 KIM, SANGUK
Dept of Life Sciences
Read more

Views & Downloads

Browse